| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/02/2012 | US20120028256 Method for providing information on antidepressant therapeutic effect using single nucleotide polymorphism |
| 02/02/2012 | US20120028255 High yielding soybean plants with low linolenic acid |
| 02/02/2012 | US20120028254 SNP Marker of Breast and Ovarian Cancer Risk |
| 02/02/2012 | US20120028253 Method for amplifying oligonucleotide and small rna by using polymerase-endonuclease chain reaction |
| 02/02/2012 | US20120028252 Human mena isoforms serve as markers of epithelial to mesenchymal transition and sensitivity to egfr inhibition in human cancer cells |
| 02/02/2012 | US20120028251 Methods and articles for detecting deoxyribonuclease activity |
| 02/02/2012 | US20120028250 Mitigation of photodamage in analytical reactions |
| 02/02/2012 | US20120028249 Anthraquinone based near ir emitting compounds and uses thereof |
| 02/02/2012 | US20120028248 Engineered fluorescent dye labeled nucleotide analogs for dna sequencing |
| 02/02/2012 | US20120028247 Plasmon sensor and manufacturing method therefor, and method for inserting sample into plasmon sensor |
| 02/02/2012 | US20120028246 Kit for detecting highly pathogenic avian influenza virus subtype h5n1 |
| 02/02/2012 | US20120028245 Quantitative analyte assay device and method |
| 02/02/2012 | US20120028244 Anti-Viral Azide Containing Compounds |
| 02/02/2012 | US20120028243 Amplification genique statistique pour l'identification sans a priori de micro-organismes par sequencage sans etape de clonage |
| 02/02/2012 | US20120028242 Biosensor for detecting multiple epitopes on a target |
| 02/02/2012 | US20120028241 Assay System for Monitoring the Effects of Genetically Engineered Cells to Alter Function of a Synctium |
| 02/02/2012 | US20120027871 Method of treatment based on polymorphisms of the kcnq1 gene |
| 02/02/2012 | US20120027870 Novel Markers for Bladder Cancer Detection |
| 02/02/2012 | US20120027807 Tissue engineered myocardium and methods of production and uses thereof |
| 02/02/2012 | US20120027799 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer |
| 02/02/2012 | US20120027770 Novel cell and therapeutical and diagnostical methods based thereon |
| 02/02/2012 | US20120027753 MicroRNAs in Never-Smokers and Related Materials and Methods |
| 02/02/2012 | US20120027750 Method and compositions for cancer prognosis |
| 02/02/2012 | US20120027749 Method |
| 02/02/2012 | US20120027744 Modified heparinase iii and methods of sequencing therewith |
| 02/02/2012 | US20120027733 Compositions to effect neuronal growth |
| 02/02/2012 | DE212010000039U1 Geräte zum erhitzen biologischer proben Equipment for heating of biological samples |
| 02/02/2012 | DE102010033575A1 ASPP2-Splicevariante ASPP2 splice variant |
| 02/02/2012 | DE102010033565A1 Marker zur Bestimmung von Chondrozyten Marker for the determination of chondrocytes |
| 02/02/2012 | DE102010033107A1 Nachweis spezifischer Nukleinsäuresequenzen mittels Fluoreszenzlöschung Detection of specific nucleic acid sequences by fluorescence quenching |
| 02/02/2012 | DE102010033105A1 Massenspektrometrische Sepsisdiagnose ohne Blutkultur Mass spectrometric sepsis diagnosis without blood culture |
| 02/02/2012 | DE102010033102A1 Determining a locus change i.e. single nucleotide polymorphism on male cattle, comprises determining the weight and/or the proportions of a fetus by molecular markers |
| 02/02/2012 | DE102010031354B3 Mittel und Verfahren zur Diagnostik, Prognose und Therapiekontrolle von Tumorerkrankungen Means and methods for diagnosis, prognosis and therapy of tumor diseases |
| 02/02/2012 | DE102009021734B4 Diagnostische Marker für die Bestimmung der Prädisposition der Entwicklung von Gebärmutterhalskrebs und für die Bestimmung eingesetzte Oligonukleotide Diagnostic markers for determining the predisposition of development of cervical cancer and for determining oligonucleotides used |
| 02/02/2012 | DE102008000715B4 Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen Method for the in vitro differentiation of pathophysiological states and Erfasssung |
| 02/02/2012 | DE102004063265B4 Verfahren zur Bestimmung der Funktion von Nukleinsäuresequenzen und den dadurch kodierten Expressionsprodukten A method for determining the function of nucleic acid sequences and the expression products encoded thereby |
| 02/02/2012 | CA2806909A1 Safe and functional humanized antibodies |
| 02/02/2012 | CA2806112A1 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors |
| 02/02/2012 | CA2805773A1 Corticogenesis of human pluripotent cells |
| 02/02/2012 | CA2804856A1 Method for the identification of catechol o-methyltransferase modulators |
| 02/02/2012 | CA2804626A1 Method for using gene expression to determine prognosis of prostate cancer |
| 02/02/2012 | CA2802567A1 Control nucleic acids for multiple parameters |
| 02/02/2012 | CA2802563A1 Generic sample preparation |
| 02/02/2012 | CA2802550A1 Generic pcr |
| 02/02/2012 | CA2802548A1 Qualitative and quantitative detection of microbial nucleic acids |
| 02/01/2012 | EP2412830A2 Compositions and methods for detection of Hepatitis A virus nucleic acid |
| 02/01/2012 | EP2412829A1 Detection of cancer cells in body fluids |
| 02/01/2012 | EP2412828A1 K-ras and B-raf mutations and anti-EGFr antibody therapy |
| 02/01/2012 | EP2412827A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 02/01/2012 | EP2412826A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 02/01/2012 | EP2412825A1 Leukemia stem cell markers |
| 02/01/2012 | EP2412824A1 Gene Expression Markers for Colorectal Cancer Prognosis |
| 02/01/2012 | EP2412823A1 Gene expression markers for colorectal cancer prognosis |
| 02/01/2012 | EP2412822A1 Gene expression markers for colorectal cancer prognosis |
| 02/01/2012 | EP2412821A1 Gene expression markers for colorectal cancer prognosis |
| 02/01/2012 | EP2412820A1 Gene expression markers for colorectal cancer prognosis |
| 02/01/2012 | EP2412819A1 Methods and uses relating to the identification of compound associated with bacterial infection |
| 02/01/2012 | EP2412818A1 Diagnosis of bacterial meningitis based on the measure of ROS production in a sample of cerebrospinal fluid |
| 02/01/2012 | EP2412805A1 Gene involved in immortalization of human cancer cell and use thereof |
| 02/01/2012 | EP2412722A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 02/01/2012 | EP2412718A1 Loop-shaped primer employed in nucleic acid amplification and the use thereof |
| 02/01/2012 | EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 02/01/2012 | EP2411809A1 Luminescence assay method |
| 02/01/2012 | EP2411808A2 Devices and methods of cell capture and analysis |
| 02/01/2012 | EP2411807A2 Methods for simultaneous generation of functional ligands |
| 02/01/2012 | EP2411545A1 Hiv vpr-specific t cell receptors |
| 02/01/2012 | EP2411544A1 Genotyping of bovine papillomavirus genotypes |
| 02/01/2012 | EP2411543A2 Methods, compositions, and kits for detecting allelic variants |
| 02/01/2012 | EP2411542A1 Polymorphism in cyp3a4 gene affecting drug metabolizing and uses thereof |
| 02/01/2012 | EP2411541A2 Markers related to age-related macular degeneration and uses therefor |
| 02/01/2012 | EP2411540A1 Genotoxicity testing |
| 02/01/2012 | EP2411539A1 Discriminatory positive/extraction control dna |
| 02/01/2012 | EP2411538A2 Method for sequencing a heteropolymeric target nucleic acid sequence |
| 02/01/2012 | EP2411537A2 Methods of predicting pairability and secondary structures of rna molecules |
| 02/01/2012 | EP2411536A2 Devices and methods for analyzing biomolecules and probes bound thereto |
| 02/01/2012 | EP2411535A1 Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor |
| 02/01/2012 | EP2411534A1 Method for diagnosing or predicting a non syndromic autosomal recessive optic atrophy, or a risk of a non syndromic autosomal recessive optic atrophy. |
| 02/01/2012 | EP2411533A1 Genetic severity markers in multiple sclerosis |
| 02/01/2012 | EP2411532A1 Pcr methods for characterizing the 5' untranslated region of the fmr1 and fmr2 genes |
| 02/01/2012 | EP2411531A1 Method for determining the predisposition of a patient to changed biotransformation and to the development of undesired pharmaceutical effects in a treatment of the patient with atorvastatin |
| 02/01/2012 | EP2411530A2 Solid phase based nucleic acid assays combining high affinity capturing and detection by specific hybridization |
| 02/01/2012 | EP2411522A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor |
| 02/01/2012 | EP2411515A1 Use of microrna-199b-5p in medical and diagnostic field |
| 02/01/2012 | EP2411509A1 Methods for the detection and treatment of aberrant prion disease |
| 02/01/2012 | EP2171084B1 Prognostic gene expression signature for non small cell lung cancer patients |
| 02/01/2012 | EP2158310B1 Optical method and device for detection and enumeration of microorganisms |
| 02/01/2012 | EP2097436B1 Heteropolynucleotide duplexes with purine-purine base pairing |
| 02/01/2012 | EP1737972B1 Protein-protein interactions for pharmacological profiling |
| 02/01/2012 | EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD |
| 02/01/2012 | EP1483416B1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 02/01/2012 | EP1472353B1 Group b streptococcus antigen |
| 02/01/2012 | EP1377677B1 Composition and method for destruction of infectious prion proteins |
| 02/01/2012 | EP1343801B1 Method for immobilising probes, in particular for producing biochips |
| 02/01/2012 | CN1894581B 检测蛋白-蛋白相互作用的方法 Detecting protein - protein interaction methods |
| 02/01/2012 | CN1656234B 包囊化核酸扩增反应混合物的微胶囊及其作为反应隔间进行平行反应的用途 Encapsulated nucleic acid amplification reaction mixture as a reaction compartment microcapsules and the use of parallel reaction |
| 02/01/2012 | CN1595153B 精浆果糖酶法定量检测试剂盒 Seminal fructose enzymatic quantitative detection kit |
| 02/01/2012 | CN102341693A Analyzer and method for sensing using the same |
| 02/01/2012 | CN102341507A Chk2 polymorphism as cancer marker |
| 02/01/2012 | CN102341506A Methods for amplifying hepatitis c virus nucleic acids |
| 02/01/2012 | CN102341505A Genetic analysis of cells |